OSP.AU · Osprey Medical, Inc

-

Please sign in to comment on OSP.AU

1 Comment

Admin

4 years, 1 month ago

Osprey Medical, Inc is currently in a long term downtrend where the price is trading 24.2% below its 200 day moving average.

From a valuation standpoint, the stock is 92.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 20.7.

Osprey Medical, Inc's total revenue sank by 53.1% to $865K since the same quarter in the previous year.

Its net income has increased by 33.0% to $-6M since the same quarter in the previous year.

Finally, its free cash flow grew by 37.0% to $-3M since the same quarter in the previous year.

Based on the above factors, Osprey Medical, Inc gets an overall score of 3/5.

Exchange	AU
CurrencyCode	AUD
Sector	Healthcare
ISIN	AU000000OSP4
Industry	Health Care Equipment & Supplies

Dividend Yield	0.0%
Market Cap	5M
PE Ratio	None
Target Price	0.26
Beta	1.37

ABOUT

Osprey Medical, Inc

Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies in the United States and internationally. It offers DyeVert Plus EZ and DyeVert Power XT, and DyeVert Plus Systems, which are used to protect patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.

OSP.AU · Osprey Medical, Inc

-

Osprey Medical, Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Osprey Medical, Inc using a moving average strategy